Cliantha Research Limited

Global contract research organization conducting bioavailability, bioequivalence, dermatology studies, clinical trials, and data management.

2004 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Cliantha Research Profile

Key Indicators

  • Authorised Capital ₹ 10.50 Cr
  • Paid Up Capital ₹ 3.78 Cr
  • Company Age 20 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 125.00 Cr
  • Satisfied Charges ₹ 9.25 Cr
  • Revenue Growth 20.38%
  • Profit Growth 14.46%
  • Ebitda 13.29%
  • Net Worth 10.28%
  • Total Assets 15.26%

About Cliantha Research

Cliantha Research Limited (CRL) is a leading Public Limited Indian Non-Government Company incorporated in India on 30 August 2004 and has a history of 20 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.

The Corporate was formerly known as Ba Research India Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.50 Cr and a paid-up capital of Rs 3.78 Cr.

The company currently has active open charges totaling ₹125.00 Cr. The company has closed loans amounting to ₹9.25 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Cliantha Research Limited India is Naveen Sharma as CEO. Mukesh Patel, Manubhai Patel, Yogendra Gupta, and Two other members serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U73100GJ2004PLC044669

  • Company No.

    044669

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    30 Aug 2004

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Cliantha Research Limited offer?

Cliantha Research Limited offers a wide range of products and services, including Graduation & High Education Programs, Medical Educational Service, Herbal & Ayurvedic Medical Services, Ayurvedic Treatment, Pharma & Bioanalytical Services, Pharmaceutical Services, Project Feasibility Studies, Market Research Service.

Company report

Cliantha Research Limited

Explore comprehensive data for Cliantha Research Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Cliantha Research?

Executive Team (1)

NameDesignationAppointment DateStatus
Naveen Sharma CEO03-Oct-2024Current

Board Members (5)

NameDesignationAppointment DateStatus
Mukesh Patel Country flag representing In Director 26-Sep-2008Current
Manubhai Patel Country flag representing In Director 31-Mar-2017Current
Yogendra Gupta Country flag representing In Director 07-Oct-2024Current
Nilima Kshirsagar Country flag representing In Director 07-Oct-2024Current
Rajiv Kamani Director 07-Oct-2024Current

Financial Performance of Cliantha Research.

Cliantha Research Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.38% increase. The company also saw a substantial improvement in profitability, with a 14.46% increase in profit. The company's net worth Soared by an impressive increase of 10.28%.

Cliantha Research revenue growth over time
Cliantha Research profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
20.38%
Revenue from Operations
20.09%
Total Assets
15.26%
Profit or Loss
14.46%
Net Worth
10.28%
EBITDA
13.29%

What is the Ownership and Shareholding Structure of Cliantha Research?

In 2023, Cliantha Research had a promoter holding of 86.28% and a public holding of 13.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹125.00 Cr

Satisfied Charges

₹9.25 Cr

Charges Breakdown by Lending Institutions

  • The Hongkong And Shanghai Banking Corporation Limited : 70.00 Cr
  • Standard Chartered Bank : 55.00 Cr

Latest Charge Details

DateLenderAmountStatus
04 Aug 2018Standard Chartered Bank₹55.00 CrOpen
17 Oct 2017The Hongkong And Shanghai Banking Corporation Limited₹70.00 CrOpen
22 Jul 2020The Hongkong And Shanghai Banking Corporation Limited₹4.25 CrSatisfied
29 May 2006Icici Bank Limited₹5.00 CrSatisfied

How Many Employees Work at Cliantha Research?

Cliantha Research has a workforce of 1239 employees as of Nov 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Cliantha Research Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cliantha Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cliantha Research's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Cliantha Research

Recent activity within the organization

  • Director Appointment

    Yogendra Kumar Gupta was appointed as a Director was appointed as a Director on 07 Oct 2024 & has been associated with this company since 6 months 25 days .

  • Director Appointment

    Nilima Arun Kshirsagar was appointed as a Director was appointed as a Director on 07 Oct 2024 & has been associated with this company since 6 months 25 days .

  • Director Appointment

    Rajiv Vikrambhai Kamani was appointed as a Director was appointed as a Director on 07 Oct 2024 & has been associated with this company since 6 months 25 days .

  • Director Appointment

    Naveen Sharma was appointed as a Ceo was appointed as a Ceo on 03 Oct 2024 & has been associated with this company since 6 months 29 days .

  • Annual General Meeting

    Cliantha Research Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Cliantha Research Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Cliantha Research Limited?

    Cliantha Research Limited was incorporated on 30 Aug 2004.

  • What is authorized share capital and paid-up capital of Cliantha Research Limited?

    The authorized share capital of Cliantha Research Limited is ₹ 10.50 Cr and paid-up capital is ₹ 3.78 Cr.

  • Who are the current board members & directors of Cliantha Research Limited?

    Currently 6 directors are associated with Cliantha Research Limited.

    • Mukesh Mangalbhai Patel
    • Manubhai Khodidas Patel
    • Yogendra Kumar Gupta
    • Nilima Arun Kshirsagar
    • Rajiv Vikrambhai Kamani
    • Naveen Sharma

  • What is the registered address of Cliantha Research Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Cliantha Research Limited is Cliantha Corporate Tp 86 Fp 28/1 Off S.P. Ring Road, Sarkhej - India, Ahmedabad, Gujarat, 382210.

  • What is the corporate identification number (CIN) and company number of Cliantha Research Limited?

    The corporate identification number (CIN) of Cliantha Research Limited is U73100GJ2004PLC044669 and the company number is 044669 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Cliantha Research Limited?

    The Official website of Cliantha Research Limited is https://www.cliantha.com

  • What has been the recent revenue trend for Cliantha Research Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Cliantha Research Limited has risen by 20.38%.

  • How many employees does Cliantha Research Limited currently have?

    As Per 2023 financial reports, 1239 employees are currently employed by Cliantha Research Limited.

  • What change has been observed in the net worth of Cliantha Research Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Cliantha Research Limited has experienced an upsurge of 10.28%.

  • What are the total open charges for Cliantha Research Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Cliantha Research Limited amount to ₹ 125.00 Cr.

  • When was the last Balance Sheet of Cliantha Research Limited filed with the ROC?

    The most recent Balance Sheet for Cliantha Research Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharma Contract R&D